Rs 100 Tablet for Cancer Recurrence Prevention! Claim by Tata Institute

Rs 100 Tablet for Cancer Recurrence Prevention! Claim by Tata Institute

Tata Institute in Mumbai, a leading cancer research and treatment center in India, has made a groundbreaking announcement. They have successfully developed a tablet that could potentially prevent cancer recurrence.

Rs 100 Tablet News Video

Tata Institute Claims Success In Cancer Treatment - With "Rs 100 Tablet"

Read More: https://t.co/dflwn3IsRH pic.twitter.com/ZWEn8DUxni

— NDTV (@ndtv) February 28, 2024

How do Cancer tablets work ?

The tablet, containing resveratrol and copper, aims to reduce cancer recurrence by generating oxygen radicals in the stomach. This process helps destroy cancer cells and prevent metastases, all while minimizing side effects of traditional treatments like radiation and chemotherapy.

Cancer Tablet Expected Price

Expected to be priced at just ₹100, the tablet is currently awaiting approval from the Food Safety and Standards Authority of India. Once approved, it is anticipated to be available in the market by June-July, offering hope to many cancer patients.

The researchers and doctors at Tata Institute have dedicated 10 years to developing this innovative tablet. Their hard work has paid off with the potential to revolutionize cancer treatment and improve the quality of life for patients.

While the results are promising, further testing and regulatory approvals are necessary before the tablet can be widely used. This discovery marks a significant milestone in cancer prevention and treatment, bringing new hope to those affected by this devastating disease.

With a price tag of just ₹100, the tablet is set to be accessible to a larger population, making it a more affordable option for cancer prevention. Once approved by the regulatory authorities, this tablet could be a game-changer in the fight against cancer, offering new possibilities for patients and their families.